Show
Sort by
-
European Academy of Allergy and Clinical Immunology position paper on endoscopic scoring of nasal polyposis
-
Responder analysis to demonstrate the effect of targeting type 2 inflammatory mechanisms with dupilumab across objective and patient‐reported endpoints for patients with severe chronic rhinosinusitis with nasal polyps in the SINUS‐24 and SINUS‐52 studies
-
- Journal Article
- A1
- open access
ARIA 2019 care pathways for allergic rhinitis in the Kuwait health care system
-
A 300 IR sublingual tablet is an effective, safe treatment for house dust mite induced allergic rhinitis : an international, double-blind, placebo-controlled, randomized phase III clinical trial
-
A responder analysis to demonstrate Dupilumab treatment effect across objective and patient-reported subjective endpoints for patients with severe chronic rhinosinusitis with nasal polyps (CRSwNP)
(2021) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. In Journal of Allergy and Clinical Immunology 147(2). p.AB132-AB132 -
- Journal Article
- A1
- open access
ARIA 2019 : um percurso assistencial integrado para a rinite alérgica em Portugal
-
- Journal Article
- A1
- open access
Heterogeneity of the pharmacologic treatment of allergic rhinitis in Europe based on MIDAS and OTCims platforms
-
Efficacy and safety of treatment with biologicals for severe chronic rhinosinusitis with nasal polyps : a systematic review for the EAACI guidelines
-
Personalized medicine for allergy treatment : allergen immunotherapy still a unique and unmatched model
-
COVID‐19 pandemic : practical considerations on the organization of an allergy clinic : an EAACI/ARIA position paper